Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEuropa Oil & Gas Regulatory News (EOG)

Share Price Information for Europa Oil & Gas (EOG)

Share Price is delayed by 15 minutes
Get Live Data
1.425    -0.05 (-3.39%)
Bid:
1.35
Ask:
1.50
Spread: 0.15 (11.111%)
Market Cap: £18.75m
EOG Live PriceLast checked at - London Stock Exchange

Intraday Europa Oil & Gas Share Chart

PrimaryBid Offer

2 Mar 2022 16:43

RNS Number : 4353D
Europa Oil & Gas (Holdings) PLC
02 March 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF EUROPA OIL & GAS (HOLDINGS) PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021) 

2 March 2022

 

Europa Oil & Gas (Holdings) plc

("EOG" or the "Company")

PrimaryBid Offer

 

Europa Oil & Gas (Holdings) plc (LON:EOG, the AIM quoted UK, Ireland and Morocco focused renewable energy, oil and gas exploration, development and production company, is pleased to announce, a conditional offer for subscription via PrimaryBid (the "PrimaryBid Offer") of new ordinary shares of 1 pence each in the Company ("New Ordinary Shares") at an issue price of 1.8 pence per New Ordinary Share (the "Issue Price"), being a discount of 21.7 per cent to the 30 day volume weighted average price on 2 March 2022. The Company is also conducting a placing of new Ordinary Shares at the Issue Price by way of an accelerated bookbuild process (the "Placing") as announced earlier.

The PrimaryBid Offer and the Placing are conditional on the general meeting to be held on 25 March 2022. The PrimaryBid Offer and the Placing are further conditional on the New Ordinary Shares to be issued pursuant to the PrimaryBid Offer and the Placing being admitted to trading on AIM ("Admission"). Admission is expected to be take place at 8.00 a.m. on 28 March 2022. The PrimaryBid Offer will not be completed without the Placing also being completed.

The Company will use the funds raised to fund the acquisition of a farm in of UKCS Block 13/23c located in the North Sea. This acquisition is in line with the Company's previously stated intention to acquire an appraisal asset to add to its existing producing assets and high impact exploration assets - thus providing investors with a more balanced asset portfolio.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid mobile app, is open to individual and institutional investors following the release of this announcement and will close at 8 p.m on 2 March 2022. The PrimaryBid Offer may close early if it is oversubscribed.

The Company reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the PrimaryBid Offer without giving any reason for such rejection.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or email PrimaryBid at enquiries@primarybid.com. 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

Europa Oil & Gas (Holdings) plc

Simon Oddie / Murray Johnson

 

mail@europaoil.com

PrimaryBid Limited

Fahim Chowdhury / James Deal

 

enquiries@primarybid.com

finnCap Ltd, Nominated Advisor

Christopher Ragget / Simon Hicks

 

+ 44 (0) 20 7220 0500

 

 

Details of the PrimaryBid Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the PrimaryBid Offer available exclusively through the PrimaryBid mobile app.

The PrimaryBid Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The PrimaryBid Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £250 per investor under the terms of the PrimaryBid Offer which is open to existing shareholders and other investors subscribing via the PrimaryBid mobile app.

For further details please refer to the PrimaryBid website at www.PrimaryBid.com. The terms and conditions on which the PrimaryBid Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on www.PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESSSFMEEESELD
Date   Source Headline
5th Jun 20263:00 pmRNSNotice of AGM
29th May 20267:00 amRNSMMHD Approval of Farm-out to Fuhai
27th May 20267:00 amRNSFinal results for 17-months to 31 December 2025
18th May 20267:00 amRNSCloughton Well - Planning Application Update
27th Apr 20267:00 amRNSNorth Yorkshire Council Decision: Cloughton Well
31st Mar 20267:00 amRNSTotal Voting Rights
27th Mar 20267:00 amRNSFEL 4/19 Licence Extension Approval
5th Mar 20262:00 pmRNSPOST TRANSACTION REPORT
5th Mar 202612:10 pmRNSHolding(s) in Company
3rd Mar 202611:50 amRNSResult of General Meeting, Admission & TVR
12th Feb 20264:13 pmRNSNotice of GM and Posting of Circular
12th Feb 20263:43 pmRNSEG-08 PSC Phase 1 Extension Finalised
12th Feb 202610:20 amRNSDirector/PDMR Shareholding
12th Feb 20267:23 amRNSResult of increased WRAP Offer, Amended GM & TVR
10th Feb 20264:30 pmRNSNotice of GM and Posting of Circular
10th Feb 20263:00 pmRNSWRAP Retail Offer for up to £350,000
10th Feb 20267:15 amRNSResults of the Placing
10th Feb 20267:00 amRNSConditional Placing to raise up to £3.5m and GM
30th Jan 20262:30 pmRNSHolding(s) in Company
30th Jan 20267:01 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSFEL 4/19 - Status of Licence
16th Jan 20267:00 amRNSPEDL343 (Cloughton) Extension
6th Jan 20262:55 pmRNSIssue of Shares, TVR and Director/PDMR Dealings
31st Dec 20258:37 amRNSDirector/PDMR Dealing
31st Dec 20258:37 amRNSDirector/PDMR Dealing
30th Dec 20253:30 pmRNSResult of AGM
30th Dec 20253:30 pmRNSResult of AGM
30th Dec 20257:00 amRNSEG-08 Farm-out Agreement Signed
30th Dec 20257:00 amRNSEG-08 Farm-out Agreement Signed
8th Dec 20257:00 amRNSNotice of AGM
20th Nov 20257:00 amRNSDL003 Extension
6th Oct 20257:00 amRNSEG-08 PSC Phase 1 Extension
15th Sep 20257:00 amRNSInterim Results
8th Sep 20257:00 amRNSNotice of Investor Presentation and Q&A Session
7th Aug 20254:23 pmRNSNotification of change in significant shareholding
5th Aug 20253:09 pmRNSDirector/PDMR Dealing
5th Aug 202512:58 pmRNSDirector/PDMR Dealing
4th Aug 20257:00 amRNSEG-08 Farm-out update
27th May 202512:06 pmRNSRevenue Swap Agreement ("RSA") Consideration
21st May 20257:00 amRNSRevenue Swap Agreement
9th Apr 20254:46 pmRNSAward of Options
8th Apr 20253:34 pmRNSDirector/PDMR Dealing
8th Apr 202511:58 amRNSDirector/PDMR Dealing
8th Apr 202511:53 amRNSHolding(s) in Company
20th Mar 202511:54 amRNSDirector/PDMR Dealing
20th Mar 20257:00 amRNSInterim Results
7th Mar 20257:00 amRNSCloughton Planning Application & Website Launch
11th Feb 20257:00 amRNSBoard Changes
31st Jan 20259:41 amRNSDirector/PDMR Dealing
31st Jan 20257:00 amRNSOperations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.